Using a liposomal transfection with purified bovine leukemia virus (BLV) integrase, we observed an efficient DNA rearrangement of a chromosomal repeat sequence and targeted integration of a part of the transfected plasmid. The BLV integrase recognition sequence (IRS) including the 3 0 end of the BLV LTR U5, one of the sites cleaved by the integrase, was essential for the DNA rearrangement, and a sequence homologous to the chromosomal DNA neighboring the repeat target site had to be placed downstream of the IRS on the transfected plasmid. The pSV2neo DNA, including the pBR322 sequence preintegrated into L929 cells (primary transfectants), was rearranged by a secondary transfection of a pBR322-based hygromycin-resistance plasmid carrying the IRS. We present a model to explain the chromosomal DNA rearrangement of the primary clones through a homologous recombination-like reaction and amplification of the neighboring sequences. Gene Therapy (2005) 12, 783-794.
Introduction
Although several methods of manipulating chromosomal genes have been reported, no highly efficient sitespecific integration or alteration of genes at a desired site has been achieved. The adeno-associated virus (AAV) vector is thought to be a hopeful vehicle to introduce a foreign gene into a definite site of the chromosome. However, the region into which a gene can be transferred is limited to an area of chromosome 19 (19.3 qter). [1] [2] [3] Modified AAV vectors are expected to become a vehicle for introducing specific changes into the genomic DNA, but the ratio of targeted to nontargeted integration events is currently about 1 to 10. 4 Although the exact mechanism of this site-specific integration is unknown, it has been speculated that the single-stranded nature of the AAV genome could promote homologous pairing. Using retroviral vector systems, the genes being introduced are integrated into the host genome and remain stable in the progeny over a long period. 5, 6 Although preferable sites for retroviral integration have been reported, 7, 8 the introduced genes are integrated almost randomly. Hence, insertion near or within a cellular gene may disrupt normal cell functions by inactivating an essential gene or by inducing inappropriate expression of an undesirable gene. Furthermore, occasional integration into protooncogenes or tumor suppressor genes accounts for the oncogenicity of gene transfer, 9 and development of leukemia associated with the use of retroviral vectors has been reported in gene therapy trials. 10 Several attempts have been made to transfer foreign gene(s) to desired site(s) using a fusion construct comprising a DNA-binding protein recognizing a specific DNA sequence and a recombinase protein. Retroviral integrase has also been used as a substrate for a fusion protein, [11] [12] [13] and although site-specific integration was achieved, the efficiency was still low; only several times higher than that of random integration.
Retroviral integrase is the essential enzyme for viral integration into the host cell chromosome. However, studies of human immunodeficiency virus type 1 (HIV-1) replication in cell culture have shown that certain mutations of the integrase protein have multiple effects. Defects occur at stages other than integration into the genome, including during reverse transcription, nuclear import and packaging. 14, 15 These functions involve mechanisms that differ from that of the well-known integration process.
Previously, we reported an increased frequency of transfection of foreign plasmid DNA carrying the bovine leukemia virus (BLV) integrase recognition sequence (BLV IRS), using purified BLV integrase. 16 We also reported a highly efficient site-specific integration of a plasmid carrying the IRS into an IRS site, which had been preintroduced into the genome of cultured mammalian cells. 17 To further investigate the role of the IRS and the integrase protein in the promotion of transfection and site-specific integration, we established neomycin-resistant (neo r ) and IRS-minus cell lines through transfection of the vector plasmid pSV2neo. 18 Further transfection experiments using these cell lines in the presence or absence of the integrase protein were then performed.
Our results indicate that targeted rearrangements of chromosomal repeat sequences occur following transfection with the integrase. A sequence homologous to the chromosomal target and the IRS were required in the introduced plasmid. The results demonstrate a new enzymatic property of the integrase protein, which is important in the understanding of the mechanism of retroviral vector integration and subsequent replication competent retrovirus (RCR) generation.
Results
Transfection of IRS-minus cell lines with a hygromycinresistance plasmid in the presence or absence of BLV integrase
Previously, we described the highly efficient (30-95%) site-specific transfer of plasmid DNA carrying the BLV IRS ( Figure 1 ), using purified BLV integrase, into a preintroduced IRS in the host genome. 17 The IRS is a 430 bp sequence containing the 3 0 end of the BLV LTR U5 region, 19 which is one of the cleavage sites recognized by the integrase.
To further investigate the role of the IRS in the host genome, we established several neomycin-resistant (neo r ), IRS-minus cell lines, by transfection with the vector plasmid pSV2neo 18 in the absence of the integrase. The pBR322 plasmid formed the backbone of the pSV2neo plasmid, similarly to the pHyg plasmid 20 used for the secondary transfection experiments. All primary clones carrying the neo r gene were stable and maintained neomycin resistance over 20 generations, with or without G418 selection. No spontaneous DNA rearrangements around the neo r gene were detected by Southern blot analysis and polymerase chain reaction (PCR) during the experimental period (data not shown). Each SVC-IRS(À) primary transfectant was further transfected with pHay2 or pHay7 (Figure 1 ), which was constructed from the plasmid pHyg 20 harboring the hyg r gene between the promoter and terminator sequences of the herpes simplex virus thymidine kinase gene (HSV-tk). The two plasmids carried the IRS downstream of the polyA sequence, but differed in the orientation of the IRS. Transfection frequencies of several SVC-IRS(À) cell lines using commercial Lipofectin reagent with pHay2 or pHay7 were low, similar to the parental cell line L929 (Table 1) . However, in the presence of the purified integrase, transfection of the pHay7 carrying an effective IRS into L929 cells was increased several folds. As described previously, 16 the increase in transfection frequency of the plasmid carrying the IRS in the presence of the integrase was orientation-dependent. The orientations of the selection marker gene and the IRS were the same as those in pHay7, and the IRS was effective. The pHay2 plasmid carried the IRS in an inverted orientation. The presence of the integrase increased the transfection frequencies for SVC-IRS(À)-6, -15 (Table 1) and -5 (data not shown) cells with pHay7, but only by a few times. All the hyg r transfectants derived from SVC-IRS(À)-15 cells were still resistant to G418 at 0.9 mg/ml. On the other hand, the SVC-IRS(À)-2, -11 and -18 cell lines showed much higher transfection frequencies in the presence of the integrase (Table 1) . For example, the transfection frequency in SVC-IRS(À)-18 cells was approx. 6 times that in SVC-IRS(À)-15 cells. In contrast to the pHay7 plasmid, the presence of integrase made no difference to the transfection frequency of the pHay2 plasmid carrying an ineffective IRS in SVC-IRS(À) 20 is transcribed from the HSV-1 tk (thymidine kinase, box with vertical stripes) promoter. The BstEII site in the tk polyA sequence (box with vertical stripes) was converted to a XhoI site using XhoI linkers. The BLV IRS (box with dense hatched lines) was also converted to a XhoI fragment and inserted downstream from the tk polyA sequence in an effective (pHay7) or ineffective (pHay2) orientation. 16 An arrow indicates the direction of the IRS, which is easily determined by the position of the NcoI site (Nc, arrow). The symbols for the restriction endonuclease sites are: Bs, BstEII; Ec, EcoRI; Nc, NcoI; Ps, PstI; Pv, PvuII; Xh, XhoI.
Targeted rearrangement using purified integrase AS Tanaka and K Komuro primary clones or in L929 cells. One clone out of four hyg r secondary transfectants derived from SVC-IRS(À)-11 cells showed decreased resistance to G418. A decrease was also observed in one hyg r secondary clone derived from SVC-IRS(À)-2 cells. The decrease suggests that in the presence of the integrase, DNA changes can occur around the neo r gene in the chromosomal DNA of the secondary tranfectants. All secondary clones from SVC-IRS(À)-18 cells showed resistance to G418 at 0.9 mg/ml. No change in G418 resistance was observed with pHyg or pHay2 on secondary transfection (data not shown).
Structure of the pSV2neo sequence integrated into primary clones
To understand the differences in the frequency of secondary transfection among the primary SVC-IRS(À) series, we have examined the structure of the pSV2neo sequence (Figure 2a (Table 1) . These results suggest that the structure of the pSV2neo-derived sequence, and especially that of the repeats integrated into the chromosomal DNA of the primary clones, somehow affects the efficiency of secondary transfection. With the use of A1 and A2 primer pairs to amplify the b-actin gene, 0.54-kb products were amplified in all SVC-IRS(À)cells (-2, -6, -11, -15 and -18) and in L929 cells.
PCR analysis to determine the structures of secondary transfectants
To determine the structure around the pSV2neo-derived sequence in secondary transfectants, PCR analyses were performed. Amplification profiles showing a difference in patterns between the primary clone and its secondary transfectants are summarized in Figure 3a and Table 2 . With the primer pair N6/N3R, a 2.0-kb product (pp6) was amplified from SVC-IRS(À)-11 cells but not from four secondary transfectants ( Figure 3a (1); IRS(À)-11- Targeted rearrangement using purified integrase AS Tanaka and K Komuro Figure 2 (a) Structures of plasmids used to establish the primary transfectants. Solid lines show the cloning vector, pBR322. The neomycin-resistance (neo r ) gene in pSV2neo, 18 which confers resistance to the neomycin analog Geneticin (G418), is transcribed from the SV40 promoter and has the SV40 polyA sequence (boxes with hatched lines). PCR products (pp1-pp7) expected from amplifications with the primers (an upstream primer/a downstream primer) are illustrated with horizontal lines with small arrows at both ends. The plasmid pSV2neo is illustrated as a partially tandem structure to show how the structures integrated into the chromosomal DNA of primary transfectants (below). The structure of the pSV2neo sequence that integrated into primary transfectants SVC-IRS(À)-2, -6, -11, -15 and -18 is also shown. Open boxes indicate the repeat sequences derived from pSV2neo that integrated into the SVC-IRS(À)-2, -11 and -18 chromosomes. Dotted vertical lines indicate the chromosomal DNA of L929 cells. The symbols for restriction endonuclease sites are: Ba, BamHI; Ec, EcoRI; Hd, HindIII; Ps, PstI; Pv, PvuII. All PstI and PvuII sites are not shown. (b) PCR analysis of the pSV2neo-derived sequence in the primary transfectants (SVC-IRS(À)-2, -6, -11, -15 and -18). PCR products (pp-numbers) amplified from the integrated pSV2neo sequence (arrows) are indicated in each panel and the primer pairs used (in parentheses) are shown below the panels. Lane M is a DNA size marker (PvuII digests of phage Lambda DNA). A1 and A2 are the primers used to amplify approx. 540-bp products (an arrow) from the b-actin gene, which is common to all the cell lines.
Targeted rearrangement using purified integrase AS Tanaka and K Komuro hg7-41, -42, -44 and -45). This product was not amplified from the primary clone SVC-IRS(À)-18 using these primers. However, four secondary transfectants (IRS(À)-18-hg7-13, -15, -17 and -18) produced the product. Primers B4 and N3R were upstream and downstream of the neo r gene, respectively. In SVC-IRS(À)-18 cells, the two primers were separated by a 46.0-kb DNA including approx. 3.5 kb of L929 chromosomal DNA (Figure 2a ; dotted vertical lines). Therefore, in the primary clone SVC-IRS(À)-18, a 2.9-kb product (pp5) was not detected with B4/N3R. However, the intervening DNA was probably deleted in the secondary transfectants obtained in the presence of the integrase. With B4/N3R, 12 secondary transfectants showed amplification of the 2.9-kb product (arrow, Figure 3a(3) ). As a result, 14 of the 17 transfectants derived from SVC-IRS(À)-18 cells showed the amplification product (Table 1 ). Nucleotide sequencing revealed that these products were identical to the pSV2neo DNA, indicating complete deletion of the intervening chromosomal DNA between the repeated pSV2neo-derived sequence in SVC-IRS(À)-18 cells. PCR analysis using other primer pairs (data not shown) also suggested deletion of the DNA region separating the B4 and N3R positions, through a homologous recombinationlike reaction that reconstructed pSV2neo around the neo r gene-SV40 polyA region. A 2.1-kb product (pp3) was not amplified from SVC-IRS(À)-11 and -18 cells with the primer pair B1/N5R, due to the lack of a B1 sequence upstream of N5R (Figure 2a) . However, three secondary clones (IRS(À)-11-hg7-41, -42 and -45) derived from SVC-IRS(À)-11 cells did produce this product (Figure 3a(2) ), and 12 secondary clones from SVC-IRS(À)-18 cells had the same amplification product (Figure 3a (2) and data not shown). hg7-7 and hg7-17 transfectants did not amplify the products. PCR with B1/B4R also showed the amplification of 1.8-kb products (pp2) in the same transfectants (Table 2) . These results suggested a highly frequent integration of DNA containing the B1 primer sequence derived from the plasmid pHay7. This process occurred through a homologous recombination-like reaction between pBR322 DNA sequences derived from the plasmid pHay7 and the integrated pSV2neo in the primary clone during the secondary transfection. A PCR analysis of secondary transfectants using primers hybridized to the hyg r gene was also performed. However, large numbers of secondary transfectants did not have the hyg r sequence near the rearranged pSV2neo DNA. One possible explanation for this result is that a large-scale DNA rearrangement around the pSV2neo sequence occurred during transfection.
Southern blot analysis of chromosomal DNA in the primary and secondary transfectants
To investigate the structures of the secondary transfectants from the SVC-IRS(À)-18 cells, Southern blotting Targeted rearrangement using purified integrase AS Tanaka and K Komuro Figure  3b(1) ). Owing to the BglII site in the intervening sequence, an approx. 1.0-kb signal was detected with BglII/(EcoRI) digestion. Southern blotting of cellular DNAs isolated from the secondary transfectants (SVC-IRS(À)-18-hg7-15, -17 and -18) showed DNA rearrangements during the transfection of the plasmid pHay7. All positive signals that hybridized with the SV2-pp probe showed a similar pattern to that of pSV2neo. For example, on digestion with HindIII (nn3092)/BamHI (nn751) and PvuII (nn2704 and nn1742), approx. 2.3 and 0.96-kb signals were detected, respectively (Figure 3b (1) and Figure 4a ). Southern blotting using the SV2-be probe, which was hybridizable to the region downstream of the SV40 polyA sequence, indicated amplification of DNA during the transfection (Figure 3b(2) ). The cellular DNA isolated from SVC-IRS(À)-18 cells did not show a positive signal. However, the cellular DNA isolated from three secondary transfectants showed similar positive signals. For example, with HindIII/PvuII and EcoRI/BamHI, approx. 3.0 and 1.4-kb bands were detected, respectively. These results suggested that the DNA region that hybridized to the SV2-be probe was amplified in the secondary transfectants. DNA amplification was also observed in Southern blotting analyses using the BR-ep probe, which hybridized to the pBR322-derived EcoRI-PstI fragment (Figure 3b(3) ). The BR-ep region was not included in the chromosomal DNA of the SVC-IRS(À)-18 cells ( Figure  2a) . Therefore, the amplified DNA was derived from the transfected pHay7 plasmid. Amplification of the BR-ep region was observed in the secondary transfectant hg7-15 and -18 cells, but not in hg7-17 cells. Similar amplifications were also observed in three secondary transfectants from the SVC-IRS(À)-11 cells transfected with pHay7 (data not shown).
Structures of the secondary transfectants and possible models for the rearrangements
The structures of secondary transfectants from SVC-IRS(À)-18 and -11 primary clones were examined by PCR and Southern blotting, and the results are illustrated in Figure 4a . In the -18 cells, one of the repeated sequences (open boxes), which included part of the neo r gene, the SV40 polyA sequence and an intervening sequence, was deleted by a homologous recombination-like reaction. The pBR322 sequence around the PstI site derived from the transfected pHay7 plasmid was introduced by a homologous recombination-like reaction between the plasmid and the pSV2neo-derived sequence in the SVC-IRS(À)-18 chromosomal DNA (Type I). On insertion and amplification of the pBR322 sequence around the EcoRI/PstI region, Type I transfectants showed positive hybridization signals with the labeled BR-ep probe (Figure 3b(3) ). Approx. 2.1-kb PCR products (pp3) were amplified with the primer pair B1/N5R (Figure 3a(2) ). Amplification was also successful in the region downstream of the neo r gene, as confirmed by hybridization using the SV2-be probe (Figure 3b(2) ). These results suggested that in Type I transfectants, the secondary transfected plasmid DNA neighboring the homologous sequences between the plasmid and chromosomal DNA was integrated. The integrated sequence is located downstream of the IRS. Type II transfectants, hg7-7 and hg7-17, showed amplifications downstream of the neo r gene, but did not show amplification of the pBR322-derived sequence in the upstream region. In the SVC-IRS(À)-11 cells, one of the repeated sequences and part of the intervening sequence were deleted by the homologous recombination-like reaction during transfection. Integration of the pHay7 plasmid DNA and amplification of the neighboring region were also observed. Amplification of the downstream region was not examined.
Schematic diagrams of the reactions are illustrated in Figure 4b . The homology between the plasmid pHay7 and SVC-IRS(À)-18 (or SVC-IRS(À)-11) cells is shown as region b1 (b2). The sequences repeated in the chromosomal DNA are shown as region c (b3). The resultant Targeted rearrangement using purified integrase AS Tanaka and K Komuro transfectants (Type I) showed integration of the sequence pb1 of pHay7 (upstream of b1), and the pb1 region was duplicated. One of the repeated sequences (c or b3) and an intervening sequence were deleted, and the downstream region (dc) was amplified. The intervening sequence (i) between the duplicated dc sequences was derived from the neighboring chromosomal DNA located downstream of the dc in SVC-IRS(À)-18 cell. Similar reactions involving b2 and pb2 were observed in secondary transfectants from SVC-IRS(À)-11 cells. These results suggest that rearrangements, including the homologous recombination-like reaction and amplification, occurred in the region neighboring the common sequence between the introduced plasmid and chromosomal DNA. The origin of the intervening sequence between the repeated pBR322-derived sequences was not identified by sequencing analysis of several clones. The sequences repeated in the chromosomal DNA were also required. The SVC-IRS(À)-2, -11 and -18 cells carried the repeats. On the other hand, SVC-IRS(À)-6 and -15 cells did not have repeat sequences. Therefore, the increase in transfection efficiency with plasmid pHay7 observed in SVC-IRS(À)-2, -11 and -18 cells in the presence of the integrase is probably due to rearrangements around the sequences repeated in the chromosomal DNA. Repeated sequences of 0.6 kb in length (SVC-IRS(À)-18 cells) are thought to be sufficient for the kind of DNA rearrangement shown in this study (Figure 2a ).
Discussion
The integration of a reverse-transcribed retroviral DNA into a host genome is essential for viral replication. 21, 22 Integration is site-specific for viral DNA at both LTRtermini, but almost random from the perspective of the host genomic DNA. Although there are certain sites on the chromosome at which integration of the viral DNA occurs more frequently, such as transcriptionally active sites, 23 the integration efficiency at these sites is only a few fold greater than that for random integration. We have previously reported that the BLV integrase mediates a highly efficient (30-95%) recombination event between the BLV IRS of a secondary transfected plasmid and an IRS that had been preintroduced into the host cell genome. 17 This recombination event may be due to the enzymatic property of the integrase, which recognizes the IRS as a target for cleaving and rejoining, 24 and may involve an unknown mechanism mediated by the integrase or a cellular enzyme(s).
In this study, we established several neo r and IRSminus cell lines by transfection of L929 cells with pSV2neo alone. These cell line (SVC-IRS(À) series, for example, SVC-IRS(À)-6) generally showed a low efficiency of secondary transfection with pHay7 carrying the IRS in the presence of the BLV integrase, compared to SVC-IRS(+) cell lines. However, the SVC-IRS(À)-2, -11 and -18 cell lines carrying repeat sequences derived from the integrated pSV2neo showed higher transfection efficiencies, and site-specific rearrangements were observed during the transfection of pHay7 (Table 1) . Southern blotting and PCR analyses of these secondary transfectants showed that DNA rearrangements occurred around the repeated sequences and the pBR322 sequences that were common between the integrated pSV2neo and the secondary transfected pHay7. Three IRS(À)-11-hg7 transfectants and approx. 70% of the IRS(À)-18-hg7 transfectants showed integration of part of the pBR322 sequence derived from pHay7 neighboring the homologous regions between the plasmid and chromosomal DNA.
It has long been observed that directly repeated sequences found within retroviral genomes are unstable. McClements et al 25 reported a deletion of a cloned integrated murine sarcoma virus provirus in recAdeficient Escherichia coli, via recombination between the viral LTRs. A highly efficient LTR-directed homologous recombination has also been observed in an HIV-1 proviral clone. 26, 27 Bischerour et al 28 suggest that Vpr stimulates HIV-1 integrase-mediated homologous strand transfer of miniviral DNA. Furthermore, Delviks and Pathak 29 have described a murine leukemia virus-based retroviral vector with a high-frequency deletion of direct repeats that can excise a drug resistance gene during reverse transcription. These reports suggest that homologous recombination-like events involving viral LTRs or direct repeat sequences can occur during the retroviral life cycle. All the viral or cellular proteins mediating these events have not been identified. However, the BLV integrase-dependent rearrangements between directly repeated sequences described here may suggest a new enzymatic property of the integrase protein. These results are also important for understanding the mechanism of RCR generation during retroviral gene therapy. Homology of the pBR322 sequence (solid lines) was found between pHay7 and the SVC-IRS(À)-18 cells. With the homologous recombination-like reaction and amplification, Type I secondary transfectants (eg, hg7-15 and hg7-18) showed bands hybridizable to the BR-ep probe, although no such signals were detected in the parent clone. Type II clones (eg, hg7-17) did not show amplification of the DNA that was hybridizable to the BR-ep probe. The primary clone SVC-IRS(À)-18 carried repeated sequences, and L929 chromosomal DNA interrupted these regions. Many secondary transfectants showed deletions of one of the repeated sequences (open boxes) and an intervening sequence after the homologous recombination-like reaction. Therefore, the structure of the pSV2neo plasmid was re-constructed. The region downstream of the neo r gene containing part of the SV40 polyA sequence was amplified, and the region hybridizable to the SV2-be probe was detected in the secondary transfectants (Figure 3b(2) ). Secondary transfectants from the SVC-IRS(À)-11 cells also contained a part of the pHay7 DNA, following the homologous recombination-like reaction of the pBR322 sequences between the plasmid and chromosomal DNA. Amplification of the introduced plasmid-derived sequence was observed. Deletion of one of the repeated sequences and part of an intervening sequence was also observed. (b) Schematic diagrams to explain DNA rearrangements. The rearrangement occurred during the transfection of the pHay7 plasmid into the primary clone in the presence of integrase. The homologous recombination-like reaction occurred between the pHay7 downstream of the IRS and chromosomal DNA (b1 or b2). The region upstream of the area of homology (pb1 or pb2) was duplicated. One of the repeated sequences in the chromosomal DNA of the primary clones (c or b3) neighboring the area of homology between the plasmid and the chromosome was deleted, along with an intervening sequence. In some cases, amplification of the region downstream of the area of homology was also observed (dc). The neighboring chromosomal DNA (i) was retained between the duplicated dc sequences.
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The role of the integrase during the rearrangements remains to be clarified. One possible role of the transfected plasmid is as a trigger for the formation of an intermediate through pairing between the homologous sequences of the chromosomal DNA and the plasmid. Another possible role is as a transporter of the integrase protein to the loci of the DNA rearrangements, through interaction with the IRS.
In our previous study, we reported that the acceleration of transfection by the integrase showed orientationdependency of the IRS. 16 These results were confirmed in this study using the hyg r plasmids, pHay2 and pHay7. The transfection frequency of pHay7 was accelerated by the integrase, but the protein had no effect on transfection of pHay2. However, due to the small numbers of secondary transfectants obtained with the pHay2 plasmid, we have not examined the DNA rearrangements around the pSV2neo-derived sequence for these clones. Therefore, further analysis will be necessary to determine the best position and orientation of the IRS in the introduced plasmid.
We have previously shown that an IRS on the chromosomal DNA was essential for site-specific integration by the integrase. 17 Therefore, the applicability of the technology was limited, because establishment of cells with the IRS on the chromosomal DNA is required. We reported a highly efficient site-specific deletion of the neo r gene from primary SVC-IRS(+) cells having an IRS pre-introduced into the chromosomal DNA by a secondary-transfected plasmid carrying the IRS. The primary transfectants carried multiple copies of the IRS (10-12) (e.g., SVC-IRS(+)-3 and -4). As the IRS was the best target for the integrase protein, the deletion of the neo r gene within the IRSs upon transfection of the plasmid carrying the IRS is an extraordinary example of the homologous recombination-like reaction described in this study. Therefore, highly efficient targeting was observed in the previous study. However, the lack of necessity for the IRS to be integrated into the chromosomal DNA, as reported in this study, is important for the general applicability of this technology.
For manipulation of the chromosomal locus, the sitespecific DNA rearrangements induced by the integrase that are described here will have to be controlled, and this may be a complicated process. However, it may be useful to delete a potentially hazardous gene from chromosomal DNA, although DNA rearrangements of the surrounding sequence may also occur. Our preliminary results show that a retroviral DNA with LTRs at both ends that is integrated into chromosomal DNA in infected cells can be efficiently deleted by introducing a plasmid DNA carrying part of the viral DNA and the IRS in the presence of the integrase (data not shown). We are planning in vivo experiments using retrovirus-infected animals after the development of technology for efficient transfer of the integrase protein and a carefully designed vector plasmid to the target cells.
Materials and methods

Purification of BLV integrase
The construction of plasmids for expressing the BLV integrase (pNXN89 or pKKN218) using a prokaryotic expression vector, pKK233-2, 31 has been reported previously. 16 The integrase was induced in E. coli JM109 by 1 mM isopropyl b-thiogalactopyranoside, and purified using its cleaving activity against an oligonucleotide that included the terminal sequence of the BLV LTR as an indicator. 24 The integrase was purified through three successive chromatographic procedures using phosphocellulose, phenyl superose (FPLC, Amersham Biosciences, Piscataway, NJ, USA) and monoQ (Amersham Biosciences) columns. Purified integrase fractions were dialyzed against buffer A (50 mM Tris-HCL (pH7.5) and 10% glycerol) and used for further analysis. Their purities (495%) were estimated by SDS-12% polyacrylamide gel electrophoresis.
Constructions of plasmids
Plasmids were constructed by the standard method, as described by Sambrook et al 32 BLV IRS (approx. 430 bp) including the 3 0 end of the BLV LTR U5 region, 19 which is the cleavage site recognized by the BLV integrase, is illustrated in Figure 1 . This fragment was ligated to the coding region of the hyg r gene. Confirmation that ligation had occurred in a correct manner was obtained by nucleotide sequencing analysis using an auto sequencing analyzer (ABI 373) and cycle sequencing kit (ThermoSequenase II dye terminator kit, Amersham Biosciences).
Cell culture and transfection
Mouse fibroblast L929 cells or primary transfectants were cultured in Dulbecco's modified Eagle's MEM (DMEM) supplemented with 10% fetal calf serum (FCS) (growth medium). For transfection, 1.25-5 ng of the purified integrase protein in buffer A and 0.67 mg of plasmid DNA in H 2 O were mixed and incubated for 30 min at room temperature. The mixture was then added to Lipofectin reagent (Invitrogen, Carlsbad, CA, USA), 33 diluted with serum-free DMEM and incubated for a further 20 min. The final mixture of Lipofectin-BLV integrase-DNA complex and 5 ml of FCS(À) DMEM were layered onto cells (5.0 Â 10 5 cells/10 cm dish) prewashed with serum-free DMEM, and the cells were then incubated for 20 h. The transfection medium was replaced with the growth medium, and the cells were further incubated. After 48 h, selection in growth medium containing 0.9 mg/ml of Geneticin (G418; Invitrogen) or 0.9 mg/ml of hygromycin B (Wako Co., Osaka, Japan) was started and continued for 12-14 days with a change of medium every 4 or 5 days. Primary G418-resistant transfectants were established by transfection of L929 cells with the pSV2neo plasmid (SVC-IRS(À) series). Secondary transfectants were established by transfection of the SVC-IRS(À) primary transfectants with the hyg r plasmids pHay2 or pHay7 (eg, the IRS(À)-11-hg7 series).
Southern blot analysis
Genomic DNA (7.5 mg) isolated from each transfectant was completely digested with a suitable restriction enzyme(s) and fractionated on a 1% agarose gel in TBE buffer. 32 Transfer to a Hybond XL nylon membrane (Amersham Biosciences) was performed as described by the manufacturer. Hybridization to a 32 P-labeled DNA probe prepared with a random prime DNA kit (Takara Shuzo, Kyoto, USA) using [a-
32 P]-dCTP (specific activity, B3000 Ci/mmol; Amersham Biosciences) was performed in Â 5 SSPE, 0.5% SDS, Â 10 Denhardt's solution, Targeted rearrangement using purified integrase AS Tanaka and K Komuro 50 mg/ml of sonicated salmon sperm DNA and B5 Â 10 5 cpm of 32 P-labeled probe/ml at 681C. The filters were washed under stringent conditions. Autoradiography was carried out at À801C for 10-14 days or for 1 day using the Bio-imaging analyzer BAS2000 (Fuji Film Co., Tokyo, Japan) at room temperature to determine the intensity of the hybridization signal.
PCR and nucleotide sequencing
The plasmid-derived sequences integrated into the chromosomal DNA in each transfectant were amplified by PCR using Ex-taq polymerase (Takara Shuzo, Kyoto, Japan). Reactions were performed using the method recommended by the manufacturer. The primers used were as follows: Nucleotide numbers are given in parentheses. Nucleotide numbering of the pSV2neo plasmid sequence (nn) starts with the EcoRI site as -1(+5729). Each of the B1/ B1R, B4/B4R, N3/N3R and N6/N6R pairs comprise complementary sequences. The amplified products were purified and sequenced. The purified PCR products were then cloned into a pGEM-T-easy vector plasmid (Promega, Madison, WI), and the nucleotide sequences were determined.
